Scion Life Sciences ("Scion"), a venture capital firm dedicated to founding and building exceptional biotechnology companies, today announced the appointment of Lalo Flores, Ph.D., Huw Nash, Ph.D. and ...

Top NHS doctor, CEO out. Across the pond, NHS England is also seeing big changes with Sir Stephen Powis announcing his plans ...

Based on component, the global 3D bioprinting market is segmented into 3D bioprinters, bioinks, software and consumables. 3D ...

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...

The center will empower collaboration ... The facility will feature advanced analytical capabilities to support research needs, including automation and digital tools, allowing teams to apply decision ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due to ...

With the results in hand, the developers of the therapy – from the Netherlands Cancer Institute and Norway's National Center for Cancer ... 4 melanoma that was too advanced to be treatable ...

Using highly advanced technologies, such as NMR spectroscopy, bioinformatics and nanotechnology, we’re finding solutions for health and environmental challenges. Science for life: Curiosity driven ...